A cancer diagnosis itself may lead to posttraumatic stress disorder (PTSD), causing depression and anxiety as well as an increased level of biomarker expression, such as interleukin-6 (IL-6), tumor necrosis factor-α (TNF-α), cortisol, and high-reactive sensitive C-reactive protein. Here, IL6 is linked to depressive symptom measurement.